RxDoctor Payments DataLook up a doctor →

Navjeet Gandhok, MD

Hematology-Oncology · Peoria, AZNPI 1851312789

Payments from drug & device makers

$18,864in general payments, 2019–2025

Across 401 payments — averaging $47.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$4K
  • Bristol Myers Squibb$3K
  • Onmark, Inc.$3K
  • Novartis$1K
  • Incyte Corporation$856
  • Seagen Inc.$837
  • plus $6K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca16$3,898
Bristol Myers Squibb21$2,932
Onmark, Inc.10$2,591
Novartis47$1,385
Incyte Corporation18$856
Seagen Inc.16$837
Merck30$645
E.r. Squibb & Sons, L.L.C.18$493
Pfizer27$405
Astellas Pharma US Inc7$388
Lilly USA, LLC15$325
Johnson & Johnson18$304
Amgen6$277
AbbVie11$257
Daiichi Sankyo Inc.10$232
Pharmacyclics LLC, An Abbvie Company8$230
Genentech USA, Inc.11$219
Spectrum Pharmaceuticals Inc.10$204
Exelixis Inc.6$159
Boehringer Ingelheim4$148
Tesaro, Inc.4$142
Genmab U.S., Inc.4$117
Gilead7$107
Bayer5$101
Sanofi4$83
Amneal Pharmaceuticals LLC3$71
Sobi, Inc3$70
Eisai Inc.3$69
Jazz Pharmaceuticals Inc.3$69
Mckesson Specialty Care Distribution, LLC1$66
Stemline Therapeutics Inc.3$65
Beigene USA, Inc.3$65
Morphosys, US Inc.3$63
EMD Serono, Inc.3$59
AVEO Pharmaceuticals, Inc.3$58
Tempus AI, Inc2$57
Blueprint Medicines Corporation2$56
Catalyst Pharmaceuticals, Inc.2$55
Coherus Oncology, Inc.2$54
Beone Medicines USA, Inc.2$49
Pharmacosmos Therapeutics Inc.2$49
Rigel Pharmaceuticals, Inc.2$42
Ipsen Biopharmaceuticals, Inc2$41
Menarini Silicon Biosystems, Inc.1$38
Takeda Pharmaceuticals U.S.A., Inc.2$33
Regeneron Healthcare Solutions, Inc.1$28
Shield Therapeutics Inc1$27
Array Biopharma Inc1$27
Springworks Therapeutics, Inc.1$27
Karyopharm Therapeutics Inc.1$24
Corcept Therapeutics1$23
Geron Corporation1$22
Taiho Oncology, Inc.1$22
Adaptive Biotechnologies Corporation1$22
Sun Pharmaceutical Industries Inc.1$20
Mirati Therapeutics, Inc.1$19
Immunocore Limited1$17
Sandoz1$16
Puma Biotechnology, Inc.1$15
Secura Bio, Inc.1$15

How this compares

Too few hematology-oncology providers in Arizonato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$2,297,213
Medicare patients
544
Services billed
161,552

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology-oncology in Peoria

See the full list for Arizona →

Where these figures come from

Is this you, or does something look wrong? →